Evidence map›Paper›PMID 17875638›Full record

ArticleInfection and immunity2007

Effect of zinc in enteropathogenic Escherichia coli infection.

John K Crane, Tonniele M Naeher, Irina Shulgina, Chengru Zhu, Edgar C Boedeker

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Mutating bothFrontiers in microbiology · 2023
    Article
  6. Effects of Zn-EnrichedNutrients · 2022
    Article
  7. Review
  8. Role of the SOS Response in the Generation of Antibiotic ResistanceAntimicrobial agents and chemotherapy · 2021
    Article
  9. Review
  10. Article
  11. Inhibition of SOS Response by Nitric Oxide Donors inFrontiers in cellular and infection microbiology · 2021
    Article
  12. Nutritional status in irritable bowel syndrome: A North American population-based study.JGH open : an open access journal of gastroenterology and hepatology · 2020
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

John K CraneDepartment of Medicine, Division of Infectious Diseases, University at Buffalo, Buffalo, New York 14214, USA. jcrane@acsu.buffalo.edu
Tonniele M Naeher
Irina Shulgina
Chengru Zhu
Edgar C Boedeker
University at Buffalo, State University of New York · USUniversity of New Mexico · US

Funding

Host Cell Killing by EPEC: Central Role in PathogenesisR01AI050652 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI CRANE, JOHN K. · 2003 to 2005
$641k
NIAID NIH HHS R01 AI 050652NIAID NIH HHS R01 AI050652PHS HHS R21 066055
6 · The paper itself

Abstract

Enteropathogenic Escherichia coli (EPEC) infection triggers the release of ATP from host intestinal cells, and the ATP is broken down to ADP, AMP, and adenosine in the lumen of the intestine. Ecto-5'-nucleotidase (CD73) is the main enzyme responsible for the conversion of 5'-AMP to adenosine, which triggers fluid secretion from host intestinal cells and also has growth-promoting effects on EPEC bacteria. In a recent study, we examined the role of the host enzyme CD73 in EPEC infection by testing the effect of ecto-5'-nucleotidase inhibitors. Zinc was a less potent inhibitor of ecto-5'-nucleotidase in vitro than the nucleotide analog alpha,beta-methylene-ADP, but in vivo, zinc was much more efficacious in preventing EPEC-induced fluid secretion in rabbit ileal loops than alpha,beta-methylene-ADP. This discrepancy between the in vitro and in vivo potencies of the two inhibitors prompted us to search for potential targets of zinc other than ecto-5'-nucleotidase. Zinc, at concentrations that produced little or no inhibition of EPEC growth, caused a decrease in the expression of EPEC protein virulence factors, such as bundle-forming pilus (BFP), EPEC secreted protein A, and other EPEC secreted proteins, and reduced EPEC adherence to cells in tissue culture. The effects of zinc were not mimicked by other transition metals, such as manganese, iron, copper, or nickel, and the effects were not reversed by an excess of iron. Quantitative real-time PCR showed that zinc reduced the abundance of the RNAs encoded by the bfp gene, by the plasmid-encoded regulator (per) gene, by the locus for the enterocyte effacement (LEE)-encoded regulator (ler) gene, and by several of the esp genes. In vivo, zinc reduced EPEC-induced fluid secretion into ligated rabbit ileal loops, decreased the adherence of EPEC to rabbit ileum, and reduced histopathological damage such as villus blunting. Some of the beneficial effects of zinc on EPEC infection appear to be due to the action of the metal on EPEC bacteria as well as on the host.

Indexed as

5'-NucleotidaseAnimalsCell Line, TumorEnteropathogenic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsFimbriae ProteinsHeLa CellsHumansIleumRabbitsZinc Acetate5'-NucleotidaseBfpA protein, E coliEscherichia coli ProteinsEspA protein, E coliFimbriae ProteinsZinc Acetate

Identifiers

PMID17875638
PMCPMC2168358
OpenAlexW2145110321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.